0.80 USD
▼-0.00-0.11%
盘后 0.79 -1.26%
2026-11-20
市值
$56.37M
市盈率
—
EPS
-0.27
股息率
—
52 周区间
0.68 – 3.82
成交量
3.36M
Beta
1.48
目标价
5.69
52W 低 0.6852W 高 3.82
价格走势
公司简介
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company’s technology platforms include EngageTx that provides a panel of optimized CD3 antibodies that can be paired with tumor-targeting antibodies to generate bispecific T-cell engagers; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology, small binding sites on large target proteins Its product pipelines for cardiometabolic disease area...